Beam Therapeutics (BEAM) Non-Current Assets (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Non-Current Assets data on file, last reported at $213.8 million in Q1 2026.

• On a quarterly basis, Non-Current Assets fell 2.49% year-over-year to $213.8 million in Q1 2026; TTM through Mar 2026 was $854.6 million, a 5.33% decrease from a year earlier, with the FY2025 full-year figure at $212.5 million, down 5.84% from the prior year.
• Non-Current Assets for Q1 2026 stood at $213.8 million, up from $212.5 million in the prior quarter.
• Over the last five years, Non-Current Assets for BEAM reached as high as $259.1 million in Q2 2023 and fell as low as $212.5 million in Q4 2025.
• Historically, Non-Current Assets has averaged $232.1 million across 5 years, with a median of $231.8 million in 2024.
• Across the five-year window, Non-Current Assets advanced 23.52% in 2022 and slipped 10.52% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $248.8 million in 2022, then retreated by 0.06% to $248.7 million in 2023, then declined by 9.25% to $225.7 million in 2024, then declined by 5.84% to $212.5 million in 2025, then advanced by 0.64% to $213.8 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $213.8 million in Q1 2026, $212.5 million in Q4 2025, and $212.5 million in Q3 2025.